Amber Arain
University of Hasselt
11 Papers
35 Citations
Amber Arain is an academic researcher from University of Hasselt. The author has contributed to research in topics: Medicine & Hepatitis C. The author has an hindex of 5, co-authored 9 publications.
Chat about Author
Papers
Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs
Geert Robaeys,Geert Robaeys,Jason Grebely,Stefan Mauss,Philip Bruggmann,Joseph Moussalli,Andrea De Gottardi,Tracy Swan,Amber Arain,Achim Kautz,Heino Stöver,Heiner Wedemeyer,Martin Schaefer,Lynn E. Taylor,Markus Backmund,Olav Dalgard,Maria Prins,Gregory J. Dore,Gregory J. Dore +18 more
TL;DR: It is demonstrated that treatment among PWID is feasible and provides a framework for HCV assessment, management, and treatment, and further research is needed to evaluate strategies to enhance assessment, adherence, and SVR among PWIDs, particularly as new treatments forHCV infection become available.
Hepatitis C in European prisons: a call for an evidence-informed response
TL;DR: Recommendations regarding hepatitis C prevention, screening and treatment in prisons have been formulated based on a literature review to assess the spread of hepatitis C among prisoners.
Enhancing Assessment and Treatment of Hepatitis C in the Custodial Setting
TL;DR: Improvements in the efficacy of HCV therapies via direct-acting antivirals mean that prison health services will be well placed for the treatment of large numbers of people with HCV who do not access health services in the community.
Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.
Amber Arain,Geert Robaeys +1 more
TL;DR: In this article, the authors highlight the most recent evidence concerning hepatitis C virus infection and treatment strategies in PWID and highlight peer support and group treatment strategies, in conjunction with greater involvement by nurse educators/practitioners, to promote greater treatment seeking and adherence by PWID.
29
Chronic Hepatitis C Treatment in Patients with Drug Injection History: Findings of the INTEGRATE Prospective, Observational Study
Geert Robaeys,Stefan Christensen,Damien Lucidarme,Amber Arain,Philip Bruggmann,Jan Kunkel,Sofia Keim,Martin Jäkel,Ralph DeMasi,Chris Liu,I. Lonjon-Domanec,Graham R. Foster +11 more
TL;DR: The findings suggest that people with a history of injecting drug use should be considered for treatment of chronic HCV infection, and highlight the need for improvements in patient support to boost retention in care and, in turn, help to prevent reinfection and transmission.